[HTML][HTML] Rapid assay for the therapeutic drug monitoring of edoxaban
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
MA Rashid, S Muneer, Y Alhamhoom, N Islam - agris.fao.org
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban.
MA Rashid, S Muneer, Y Alhamhoom, N Islam - Biomolecules, 2022 - europepmc.org
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
[HTML][HTML] Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
MA Rashid, S Muneer, Y Alhamhoom, N Islam - Biomolecules, 2022 - ncbi.nlm.nih.gov
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
MA Rashid, S Muneer, Y Alhamhoom, N Islam - Biomolecules, 2022 - eprints.qut.edu.au
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
MA Rashid, S Muneer, Y Alhamhoom, N Islam - Biomolecules, 2022 - search.proquest.com
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
[PDF][PDF] Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
MA Rashid, S Muneer, Y Alhamhoom… - Anal. Chim …, 2017 - pdfs.semanticscholar.org
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban.
MA Rashid, S Muneer… - Biomolecules (2218 …, 2022 - search.ebscohost.com
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban
MA Rashid, S Muneer, Y Alhamhoom… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …
treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its …